标普和纳斯达克内在价值 联系我们

Cannonau Corp. CNNC OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
70/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cannonau Corp. (CNNC) 当前追踪市盈率 (P/E) 为 0.1. 追踪盈利收益率为 714.29%.

本页证实的标准:

  • VALUE (100/100, 通过) — 市盈率低于市场平均水平 (0.1); 盈利收益率超过债券收益率 (714.29%).
  • 追踪盈利收益率 714.29% — 超过典型债券收益率(约4.3%),使股票相对固定收益更具吸引力。

SharesGrow 综合评分: 66/100 其中 2/7 项标准通过。

SharesGrow 7-Criteria Score
70/100
SG Score
View full scorecard →
价值
100/100
Price-to-Earnings & upside
Proven by this page
未來
N/A
No coverage
过去
25/100
→ Income
健康
83/100
Debt-to-Equity & liquidity
→ Health
~
护城河
50/100
→ Income
成长
90/100
→ Income
收入
N/A
No coverage

估值概览 — CNNC

估值倍数
P/E (TTM)0.1
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率714.29%
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2014 $0.00 $0.00 $0.00 -
2015 $0.00 $0.00 $0.00 -
2016 $0.00 $0.00 $0.00 -
2017 $0.00 $0.00 $0.00 -
2018 $0.00 $0.00 $0.00 -
2019 $-1.48 $0.00 $-74.28K -
2020 $0.00 $1.84K $-86.53K -4715.7%
2021 $0.00 $6.18K $-149K -2411%
2022 $0.00 $227.00 $-85.95K -37863.4%
2023 $0.00 $0.00 $338.24K -
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言